Your browser doesn't support javascript.
loading
[Bioavailability of heptaminol in healthy subjects]. / Untersuchungen zur Bioverfügbarkeit von Heptaminol bei Probanden.
Kees, F; Dominiak, P; Grobecker, H.
Afiliação
  • Kees F; Lehrstuhl für Pharmakologie der Universität Regensburg.
Arzneimittelforschung ; 37(10): 1182-5, 1987 Oct.
Article em De | MEDLINE | ID: mdl-3435592
ABSTRACT
In ten healthy volunteers the plasma and urine concentrations of heptaminol (Heptylon) were determined by high-performance liquid chromatography after intravenous administration of 250 mg heptaminol and oral intake of 2 x 150 mg heptaminol in tablet form, and the pharmacokinetic parameters were calculated. Heptaminol was rapidly and entirely absorbed following oral administration of heptaminol. Mean plasma peak concentrations of 1.6 mg/l were reached after 1.8 h, the area under the plasma concentration-time curve was equal to that after intravenous administration. The dominant terminal plasma half-life was 2.5-2.7 h. The total clearance amounted to 700 ml/min, and nearly all the dose given was recovered unchanged in urine within 24 h, indicating renal elimination by glomerular filtration and tubular secretion without metabolization.
Assuntos
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amino Álcoois / Heptaminol Limite: Adult / Female / Humans / Male Idioma: De Revista: Arzneimittelforschung Ano de publicação: 1987 Tipo de documento: Article
Buscar no Google
Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amino Álcoois / Heptaminol Limite: Adult / Female / Humans / Male Idioma: De Revista: Arzneimittelforschung Ano de publicação: 1987 Tipo de documento: Article